14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Mon, 20 May 2024

Trading levels for HALO

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 46.34 3.65 %
R2 45.81 2.45 %
R1 45.48 1.71 %
Current price: 44.71
Support S1 44.40 -0.690 %
S2 44.07 -1.43 %
S3 43.53 -2.63 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0 .
R2 45.82 2.48 %
R1 45.39 1.52 %
Current price 44.71
Support S1 42.01 -6.04%
S2 40.86 -8.61%
S3 38.36 -14.20%

HALO Predictions History

5 years ago
NameNotImportant predicted that HALO for 2019-04-29 is going $16.20 (-0.12%)

5 years ago
NameNotImportant predicted that HALO for 2019-04-23 is going $16.40 (0.00%)

6 years ago
Dragodin predicted that HALO for 2018-02-26 is going $19.90 (0.15%)

Rank:

6 years ago
JS predicted that HALO for 2018-02-26 is going $19.72 (-0.75%)

6 years ago
Hicham.Zen.18702 predicted that HALO for 2018-02-26 is going $19.49 (-1.91%)

Rank:

6 years ago
Mark.Sanders.11633 predicted that HALO for 2018-02-26 is going $19.17 (-3.52%)

Rank:

7 years ago
JS predicted that HALO for 2017-04-17 is going $12.87 (0.47%)

Click to get the best stock tips daily for free!

About Halozyme Therapeutics

Halozyme Therapeutics Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable biologics, such as monoclonal antibodies and other therapeutic molecules, as well as small molecules a... HALO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT